AI Detection System, Critical Limb Ischemia Device Gain FDA 'Breakthrough' Status

Two companies disclosed Breakthrough Device designations from US FDA on Jan. 29, one for an artificial intelligence tool for detecting intracranial hemorrhage, and the other for a system to treat critical limb ischemia.

[Editor's note: For a list of publicly disclosed breakthrough devices and status details, check out Medtech Insight'sUS Breakthrough Devices Tracker.]

US FDA has recently selected an artificial intelligence (AI) software tool to help detect intracranial hemorrhage and a novel catheter/stent...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

PathAI Expands AISight Dx Label With PCCP-Guided Addition Of Roche Scanners

 

Roche’s scanners have been integrated with PathAI’s AISight Dx system. The system’s FDA-cleared PCCP allows new components to be validated and integrated without additional FDA clearance. Eric Walk, chief medical officer, hints at future biopharma companion diagnostic collaborations.

‘Serious Flaws’ In Medicare’s Proposal To Restart DME Competitive Bidding, AdvaMed Says

 

A proposed rule from Medicare would impact essential devices for many beneficiaries. AdvaMed says the rule would reduce incentives for companies to innovate and criticizes CMS for not providing the necessary information stakeholders need to fully understand the proposal’s implications.

Which Countries Have Adopted International Regulatory Alignment Documents?

 

Just ahead of its 28th meeting, the International Medical Device Regulators Forum has released a summary of the global uptake of its documents.

European Commission Review of the MDR and IVDR – Where Are We Right Now?

 

Political and regulatory pressures make revising the EU’s medtech regulations a tricky balancing act, two renowned medtech experts, Erik Vollebregt and Bassil Akra told Medtech Insight during a recent interview.

More from Policy & Regulation

PathAI Expands AISight Dx Label With PCCP-Guided Addition Of Roche Scanners

 

Roche’s scanners have been integrated with PathAI’s AISight Dx system. The system’s FDA-cleared PCCP allows new components to be validated and integrated without additional FDA clearance. Eric Walk, chief medical officer, hints at future biopharma companion diagnostic collaborations.

Small, Sleek, Ambitious: ViCentra Raises $85M To Develop Kaleido 2 Insulin Pump, Eyes US Market

 
• By 

Dutch insulin pump maker ViCentra secured $85m to scale European manufacturing, preparing for the 2026 launch of its thinner, lighter Kaleido 2 pump and push into US market. CEO Tom Arnold said the pump has more than 3,500 users in Europe and expects “tens of thousands” in the next 18 months.

‘Serious Flaws’ In Medicare’s Proposal To Restart DME Competitive Bidding, AdvaMed Says

 

A proposed rule from Medicare would impact essential devices for many beneficiaries. AdvaMed says the rule would reduce incentives for companies to innovate and criticizes CMS for not providing the necessary information stakeholders need to fully understand the proposal’s implications.